当前位置:首页 - 行情中心 - 维康药业(300878) - 财务分析 - 现金流量表

维康药业

(300878)

  

流通市值:46.00亿  总市值:46.22亿
流通股本:1.44亿   总股本:1.45亿

现金流量表

报告期2026-03-312025-12-312025-09-302025-06-30
公司类型通用通用通用通用
一、经营活动产生的现金流量:
  销售商品、提供劳务收到的现金36,935,987.22220,764,813.04159,513,871.68120,832,916.21
  收到的税费返还-2,189,996.782,140,993.42-
  收到其他与经营活动有关的现金5,264,900.264,610,585.4349,703,801.6343,375,360.12
  经营活动现金流入小计42,200,887.42287,565,395.25211,358,666.73164,208,276.33
  购买商品、接受劳务支付的现金13,764,07550,226,980.0937,395,340.6625,761,819.55
  支付给职工以及为职工支付的现金20,217,263.2471,002,895.3854,844,130.4738,017,402.71
  支付的各项税费11,676,199.737,737,768.677,533,625.277,347,676.37
  支付其他与经营活动有关的现金17,440,291.1891,508,294.0368,604,102.0548,676,312
  经营活动现金流出小计63,097,829.15220,475,938.17168,377,198.45119,803,210.63
  经营活动产生的现金流量净额-20,896,941.7367,089,457.0842,981,468.2844,405,065.7
二、投资活动产生的现金流量:
  处置固定资产、无形资产和其他长期资产收回的现金净额63,30188,00050,00050,000
  处置子公司及其他营业单位收到的现金净额-44,625,315.6844,625,315.6844,625,315.68
  投资活动现金流入小计63,30144,713,315.6844,675,315.6844,675,315.68
  购建固定资产、无形资产和其他长期资产支付的现金8,511,396.0267,171,199.3228,716,102.9221,766,524.97
  支付其他与投资活动有关的现金-20,000,00010,000,00010,000,000
  投资活动现金流出小计8,511,396.0287,171,199.3238,716,102.9231,766,524.97
  投资活动产生的现金流量净额-8,448,095.02-42,457,883.645,959,212.7612,908,790.71
三、筹资活动产生的现金流量:
  取得借款收到的现金84,000,00065,300,00011,000,00011,000,000
  收到其他与筹资活动有关的现金-120,365.13--
  筹资活动现金流入小计84,000,00065,420,365.1311,000,00011,000,000
  偿还债务支付的现金9,000,000187,822,417.0525,261,33525,261,335
  分配股利、利润或偿付利息支付的现金1,613,606.1328,421,718.0925,328,395.4124,004,842.31
  支付其他与筹资活动有关的现金-231,937.65--
  筹资活动现金流出小计10,613,606.13216,476,072.7950,589,730.4149,266,177.31
  筹资活动产生的现金流量净额73,386,393.87-151,055,707.66-39,589,730.41-38,266,177.31
五、现金及现金等价物净增加额44,041,357.12-126,424,134.229,350,950.6319,047,679.1
  加:期初现金及现金等价物余额137,185,199.57253,609,333.79253,609,333.79253,609,333.79
  期末现金及现金等价物余额181,226,556.69127,185,199.57262,960,284.42272,657,012.89
补充资料:
  净利润--229,731,806.47--64,311,059.43
  资产减值准备-97,535,670.57--1,542,952.71
  固定资产和投资性房地产折旧-61,501,481.03-27,711,026.25
  其中:固定资产折旧、油气资产折耗、生产性生物资产折旧-61,501,481.03-27,711,026.25
  无形资产摊销-1,376,622.22-890,357.91
  长期待摊费用摊销-1,103,322.35-30,288.74
  处置固定资产、无形资产和其他长期资产的损失-992,596.01-493,861.61
  固定资产报废损失-654,840.48-1,295
  公允价值变动损失-12,478,791.23--
  财务费用-6,273,431.92-3,782,750.26
  投资损失--1,120,000-0
  递延所得税-20,418,912.78-6,779,378.07
  其中:递延所得税资产减少-19,435,425.8-6,826,723.44
    递延所得税负债增加-983,486.98--47,345.37
  存货的减少-57,453,727.24-10,252,134.7
  经营性应收项目的减少-165,639,258.36-75,788,133.9
  经营性应付项目的增加--127,487,390.64--16,114,654.3
  现金的期末余额-127,185,199.57-272,657,012.89
  减:现金的期初余额-253,609,333.79-253,609,333.79
  现金及现金等价物的净增加额--126,424,134.22-19,047,679.1
公告日期2026-04-292026-04-292025-10-302025-08-28
审计意见(境内)标准无保留意见
TOP↑